+

AU2003256922A1 - Substituted heterocyclic compounds as modulators of the ccr5 receptor - Google Patents

Substituted heterocyclic compounds as modulators of the ccr5 receptor

Info

Publication number
AU2003256922A1
AU2003256922A1 AU2003256922A AU2003256922A AU2003256922A1 AU 2003256922 A1 AU2003256922 A1 AU 2003256922A1 AU 2003256922 A AU2003256922 A AU 2003256922A AU 2003256922 A AU2003256922 A AU 2003256922A AU 2003256922 A1 AU2003256922 A1 AU 2003256922A1
Authority
AU
Australia
Prior art keywords
modulators
substituted heterocyclic
heterocyclic compounds
ccr5 receptor
ccr5
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003256922A
Other versions
AU2003256922A8 (en
Inventor
William E. Bondinell
Michael J. Neeb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2003256922A8 publication Critical patent/AU2003256922A8/en
Publication of AU2003256922A1 publication Critical patent/AU2003256922A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003256922A 2002-07-31 2003-07-28 Substituted heterocyclic compounds as modulators of the ccr5 receptor Abandoned AU2003256922A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40025602P 2002-07-31 2002-07-31
US60/400,256 2002-07-31
PCT/US2003/023523 WO2004010942A2 (en) 2002-07-31 2003-07-28 Substituted heterocyclic compounds as modulators of the ccr5 receptor

Publications (2)

Publication Number Publication Date
AU2003256922A8 AU2003256922A8 (en) 2004-02-16
AU2003256922A1 true AU2003256922A1 (en) 2004-02-16

Family

ID=31188673

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003256922A Abandoned AU2003256922A1 (en) 2002-07-31 2003-07-28 Substituted heterocyclic compounds as modulators of the ccr5 receptor

Country Status (2)

Country Link
AU (1) AU2003256922A1 (en)
WO (1) WO2004010942A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7479496B2 (en) 2004-02-19 2009-01-20 Bristol-Myers Squibb Company Substituted spiro azabicyclics as modulators of chemokine receptor activity
US7230022B2 (en) 2004-02-19 2007-06-12 Bristol-Myers Squibb Company Substituted fused bicyclic amines as modulators of chemokine receptor activity
US7288563B2 (en) 2004-02-19 2007-10-30 Bristol-Myers Squibb Company Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7381738B2 (en) 2004-02-19 2008-06-03 Bristol-Myers Squibb Company Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
KR20070034524A (en) 2004-05-28 2007-03-28 버텍스 파마슈티칼스 인코포레이티드 Muscarinic receptor modulators
EP1781288A2 (en) 2004-08-19 2007-05-09 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US7786141B2 (en) 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
CN101155587A (en) 2004-11-29 2008-04-02 弗特克斯药品有限公司 Modulators of muscarinic receptors
EP1988892A2 (en) 2006-02-22 2008-11-12 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US7858790B2 (en) 2006-06-29 2010-12-28 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
ES2571533T3 (en) 2007-04-27 2016-05-25 Purdue Pharma Lp TRPV1 antagonists and uses thereof
EP2575815A4 (en) 2010-06-04 2013-12-25 Albany Molecular Res Inc Glycine transporter-1 inhibitors, methods of making them, and uses thereof
US8980924B2 (en) 2010-11-24 2015-03-17 The Trustees Of Columbia University In The City Of New York Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease
AU2012273652B2 (en) 2011-06-22 2015-09-03 Purdue Pharma L.P. TRPV1 antagonists including dihydroxy substituent and uses thereof
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
MX2014015933A (en) 2012-06-20 2015-07-17 Novartis Ag Complement pathway modulators and uses thereof.
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
EP3495357B1 (en) 2013-03-14 2021-05-05 The Trustees of Columbia University in the City of New York 4-phenylpiperidines, their preparation and use
ES2700541T3 (en) 2013-03-14 2019-02-18 Univ Columbia Octahidrociclopentapirroles, its preparation and use
US9434727B2 (en) 2014-04-30 2016-09-06 The Trustees Of Columbia University In The City Of New York Substituted 4-phenylpiperidines, their preparation and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001280599A1 (en) * 2000-07-15 2002-01-30 Smith Kline Beecham Corporation Compounds and methods
IL154514A0 (en) * 2000-08-18 2003-09-17 Millennium Pharm Inc Quinazoline derivatives and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
AU2003256922A8 (en) 2004-02-16
WO2004010942A3 (en) 2004-07-08
WO2004010942A2 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
AU2003254177A1 (en) Substituted benzanilides as modulators of the ccr5 receptor
AU2003256922A1 (en) Substituted heterocyclic compounds as modulators of the ccr5 receptor
AU2003256923A1 (en) Substituted benzanilides as modulators of the ccr5 receptor
AU2003253535A1 (en) N-4-piperidinyl compounds as ccr5 modulators
AU2003259482A1 (en) N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators
AU2002353403A1 (en) Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators
AU2003281355A1 (en) Modulators of the glucocorticoid receptor
EP1656138A4 (en) Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
AU2003265128A1 (en) Positive allosteric modulators of the nicotinic acetylcholine receptor
IL164261A0 (en) Tropane derivatives as ccr5 modulators
AU2003245773A1 (en) Vanilloid receptor modulators
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
EG25893A (en) Pyrimid sulfonamide derivatives as modulators of chemokine receptor
AU2003218374A1 (en) Substituted tetrahydroisoquinolines as c5a receptor modulators
DE602004014772D1 (en) PYRROL-2,5-DITHION DERIVATIVES AS MODULATORS OF THE LIVER-X RECEPTOR
AU2003212770A1 (en) Piperidine derivatives useful as modulators of chemokine receptor activity
AU2003301216A1 (en) Novel use of liver x receptor agonists
AU2003301299A1 (en) Benzyl substituted (piperidin-4-yl) aminobenzamido derivatives as delta-opiod receptor modulators
AU2002347552A1 (en) 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
AU2003288854A1 (en) Novel piperidine derivatives as modulators of chemokine receptor ccr5
AU2003227919A1 (en) Dopamine receptor modulators as antipsychotic agents
AU2003280578A1 (en) Heterocyclic compounds
AU2003226396A1 (en) Imidazolidine compounds as chemokine receptor modulators
AU2003301095A1 (en) 4(spiropiperidinyl)methyl substituted pyrrolidines as modulators of chemokine receptor activity
AU2002322400A1 (en) Aza-cyclic compounds as modulators of acetylcholine receptors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载